SG11201805204WA - Nicotine particle capsule - Google Patents
Nicotine particle capsuleInfo
- Publication number
- SG11201805204WA SG11201805204WA SG11201805204WA SG11201805204WA SG11201805204WA SG 11201805204W A SG11201805204W A SG 11201805204WA SG 11201805204W A SG11201805204W A SG 11201805204WA SG 11201805204W A SG11201805204W A SG 11201805204WA SG 11201805204W A SG11201805204W A SG 11201805204WA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- pct
- capsule
- english
- december
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title abstract 4
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 3
- 229960002715 nicotine Drugs 0.000 title abstract 3
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title abstract 3
- 239000002245 particle Substances 0.000 title abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/243—Nicotine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/186—Treatment of tobacco products or tobacco substitutes by coating with a coating composition, encapsulation of tobacco particles
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F15/00—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor
- A24F15/01—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor specially adapted for simulated smoking devices or cigarettes therefor
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
- A24F42/20—Devices without heating means
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
- A24F42/60—Constructional details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0035—Piercing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15202712 | 2015-12-24 | ||
| EP16201580 | 2016-11-30 | ||
| PCT/IB2016/057792 WO2017109678A1 (fr) | 2015-12-24 | 2016-12-19 | Capsule de particule de nicotine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201805204WA true SG11201805204WA (en) | 2018-07-30 |
Family
ID=57822002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805204WA SG11201805204WA (en) | 2015-12-24 | 2016-12-19 | Nicotine particle capsule |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10960152B2 (fr) |
| EP (1) | EP3393565B1 (fr) |
| JP (1) | JP7242300B2 (fr) |
| KR (1) | KR102697599B1 (fr) |
| CN (1) | CN108430551A (fr) |
| AU (1) | AU2016376033A1 (fr) |
| BR (1) | BR112018010830B1 (fr) |
| CA (1) | CA3008996A1 (fr) |
| ES (1) | ES2948157T3 (fr) |
| IL (1) | IL259910A (fr) |
| MX (1) | MX2018007512A (fr) |
| PH (1) | PH12018501199A1 (fr) |
| PL (1) | PL3393565T3 (fr) |
| RU (1) | RU2720573C2 (fr) |
| SG (1) | SG11201805204WA (fr) |
| UA (1) | UA123586C2 (fr) |
| WO (1) | WO2017109678A1 (fr) |
| ZA (1) | ZA201803662B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3589146B1 (fr) | 2017-02-28 | 2023-04-05 | Philip Morris Products S.A. | Dispositif de génération d'aérosol comprenant un actuateur de-agglomération |
| MX2019014671A (es) * | 2017-06-28 | 2020-02-07 | Philip Morris Products Sa | Contenedor con particulas para su uso con un inhalador. |
| PL3700611T3 (pl) | 2017-10-25 | 2022-03-21 | Philip Morris Products S.A. | Akcesorium przebijające dla wyrobu inhalatorowego i układu |
| JP7431727B2 (ja) * | 2017-10-25 | 2024-02-15 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | 境界要素を備えた吸入器 |
| CN111465423B (zh) * | 2017-12-28 | 2022-08-16 | 菲利普莫里斯生产公司 | 具有涡旋通道的吸入器 |
| WO2019159123A1 (fr) * | 2018-02-19 | 2019-08-22 | Philip Morris Products S.A. | Inhalateur de poudre sèche |
| EP3772252B1 (fr) | 2018-03-26 | 2022-05-04 | Philip Morris Products S.A. | Inhalateur comprenant un élément de support poreux perforé |
| KR102724157B1 (ko) | 2018-03-26 | 2024-11-01 | 필립모리스 프로덕츠 에스.에이. | 복합 다공성 지지 요소를 갖는 흡입기 물품 및 시스템 |
| EP3772258B1 (fr) * | 2018-03-26 | 2023-10-25 | Philip Morris Products S.A. | Inhalateur comportant une cavité de capsule de vortex |
| CN114375210B (zh) * | 2019-09-26 | 2024-08-27 | 菲利普莫里斯生产公司 | 具有扭转型远端元件的吸入器制品 |
| KR20220088421A (ko) * | 2019-10-25 | 2022-06-27 | 필립모리스 프로덕츠 에스.에이. | 개방 원위 단부 및 흡입기 시스템을 갖는 흡입기 물품 |
| KR20220087453A (ko) * | 2019-10-25 | 2022-06-24 | 필립모리스 프로덕츠 에스.에이. | 접선 방향 기류 단부 요소를 갖는 흡입기 물품 |
| BR112022016859A2 (pt) * | 2020-02-26 | 2022-10-25 | Philip Morris Products Sa | Bocal de inalador com elemento aromatizante |
| JPWO2022071583A1 (fr) * | 2020-10-02 | 2022-04-07 | ||
| CN116829008A (zh) * | 2020-12-18 | 2023-09-29 | 菲利普莫里斯生产公司 | 具有中空管状元件的吸入器制品 |
| KR102883789B1 (ko) | 2023-01-10 | 2025-11-11 | 주식회사 켐에쎈 | 공연 경로 프레임 편집 및 충돌 회피 기반 공연 경로 프레임 일괄 자동 생성을 통한 군집 드론 공연 경로 구성 방법 |
| CN116982724A (zh) * | 2023-08-29 | 2023-11-03 | 东莞市吉纯生物技术有限公司 | 一种肉桂茶香口含制品及其制备方法 |
| KR102801986B1 (ko) | 2024-11-20 | 2025-04-30 | 주식회사 유닉트 | 군집 드론 제어 시스템 및 제어 방법 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
| GB1521000A (en) * | 1975-06-13 | 1978-08-09 | Syntex Puerto Rico Inc | Inhalation device |
| US4695274A (en) | 1986-01-31 | 1987-09-22 | Fox Richard L | Protected hypodermic needle |
| US4790305A (en) | 1986-06-23 | 1988-12-13 | The Johns Hopkins University | Medication delivery system |
| US4735217A (en) | 1986-08-21 | 1988-04-05 | The Procter & Gamble Company | Dosing device to provide vaporized medicament to the lungs as a fine aerosol |
| GB8804069D0 (en) | 1988-02-22 | 1988-03-23 | Britains Petite Ltd | Dispensers for powdered medication |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| NO168921C (no) | 1989-07-31 | 1992-04-22 | Svein Knudsen | Roekfri sigaretterstatning til bruk ved roekavvenning ellertil bruk i roekfrie miljoeer |
| US5441060A (en) | 1993-02-08 | 1995-08-15 | Duke University | Dry powder delivery system |
| PT101450B (pt) * | 1994-02-02 | 1999-11-30 | Hovione Produtos Farmaceuticos | Novo dispositivo para inalacao |
| US6102036A (en) | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler |
| US6234169B1 (en) * | 1998-08-14 | 2001-05-22 | Arthur Slutsky | Inhaler |
| GB0009468D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formulations for use in inhaler devices |
| PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
| US20040206350A1 (en) | 2002-12-19 | 2004-10-21 | Nektar Therapeutics | Aerosolization apparatus with non-circular aerosolization chamber |
| US20050081852A1 (en) * | 2002-12-30 | 2005-04-21 | Nektar Therapeutics (Formely Inhale Therapeutic System Inc.) | Package for an aerosolization apparatus and pharmaceutical formulation receptacle |
| US20050056280A1 (en) * | 2002-12-31 | 2005-03-17 | Nektar Therapeutics | Receptacle for an aerosolizable pharmaceutical formulation |
| WO2004060351A2 (fr) * | 2002-12-31 | 2004-07-22 | Nektar Therapeutics | Formulation pharmaceutique ayant un agent actif insoluble |
| US7669596B2 (en) * | 2002-12-31 | 2010-03-02 | Novartis Pharma Ag | Aerosolization apparatus with rotating capsule |
| US20060254583A1 (en) * | 2003-03-20 | 2006-11-16 | Arthur Deboeck | Dry powder inhaler system |
| ES2872350T3 (es) * | 2003-06-13 | 2021-11-02 | Civitas Therapeutics Inc | Polvos farmacéuticos de dosis baja para inhalación |
| GB2415597A (en) * | 2004-07-01 | 2006-01-04 | Christopher Owen Hackling | Cigarette |
| US7836922B2 (en) | 2005-11-21 | 2010-11-23 | Mannkind Corporation | Powder dispenser modules and powder dispensing methods |
| GB2461008B (en) | 2006-12-08 | 2011-08-10 | Exchange Supplies Ltd | Nicotine inhalation device |
| EP2134395B1 (fr) | 2007-03-30 | 2020-03-18 | Philip Morris Products S.A. | Dispositif pour administrer un médicament |
| BRPI0821111A2 (pt) | 2007-12-05 | 2015-06-16 | Novartis Ag | Recptáculo para uma formulação farmacêutica aerossoliza´vel |
| US8485180B2 (en) * | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| AT507631B1 (de) * | 2008-11-26 | 2012-05-15 | Haas Rouven Mag | Vorrichtung zum ansaugen von pulver- oder granulat-material und kapsel hierfür |
| UA97784C2 (ru) | 2009-02-23 | 2012-03-12 | Джапан Тобакко Инк. | Ненагреваемое устройство для всасывания табачного аромата |
| US8813759B1 (en) | 2010-11-18 | 2014-08-26 | Richard C. Horian | Nicotine inhaler and method of manufacture |
| WO2012078804A1 (fr) | 2010-12-07 | 2012-06-14 | Respira Therapeutics, Inc. | Inhalateur de poudre sèche |
| PL2714162T3 (pl) | 2011-05-27 | 2020-08-24 | Boehringer Ingelheim International Gmbh | Inhalator i kapsułka do inhalatora |
| US10786637B2 (en) | 2011-07-13 | 2020-09-29 | Pharmaxis Ltd. | Delivery devices |
| US20140088044A1 (en) | 2012-09-21 | 2014-03-27 | Basil Rigas | Product comprising a nicotine-containing material and an anti-cancer agent |
| ES2743898T3 (es) | 2014-04-28 | 2020-02-21 | Philip Morris Products Sa | Inhalador de polvo nicotina |
| RU2680422C2 (ru) * | 2014-04-28 | 2019-02-21 | Филип Моррис Продактс С.А. | Ингалятор ароматизированного никотинового порошка |
| KR102395956B1 (ko) * | 2014-06-20 | 2022-05-10 | 필립모리스 프로덕츠 에스.에이. | 기류 관리 수단을 보유한 니코틴 분말 전달 시스템 |
| PL3160271T3 (pl) * | 2014-06-27 | 2020-05-18 | Philip Morris Products S.A. | Układ wytwarzania aerozolu z ulepszonym elementem przebijającym |
| KR102641134B1 (ko) * | 2015-04-15 | 2024-02-28 | 필립모리스 프로덕츠 에스.에이. | 흡입 디바이스를 위한 향료 요소 |
| US20170071248A1 (en) * | 2015-09-16 | 2017-03-16 | Sansa Corporation (Barbados) Inc. | System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations |
-
2016
- 2016-12-19 WO PCT/IB2016/057792 patent/WO2017109678A1/fr not_active Ceased
- 2016-12-19 MX MX2018007512A patent/MX2018007512A/es unknown
- 2016-12-19 BR BR112018010830-8A patent/BR112018010830B1/pt active IP Right Grant
- 2016-12-19 KR KR1020187016263A patent/KR102697599B1/ko active Active
- 2016-12-19 RU RU2018126867A patent/RU2720573C2/ru active
- 2016-12-19 SG SG11201805204WA patent/SG11201805204WA/en unknown
- 2016-12-19 ES ES16826768T patent/ES2948157T3/es active Active
- 2016-12-19 US US16/064,177 patent/US10960152B2/en active Active
- 2016-12-19 JP JP2018530623A patent/JP7242300B2/ja active Active
- 2016-12-19 EP EP16826768.0A patent/EP3393565B1/fr active Active
- 2016-12-19 CN CN201680071326.0A patent/CN108430551A/zh active Pending
- 2016-12-19 UA UAA201803894A patent/UA123586C2/uk unknown
- 2016-12-19 AU AU2016376033A patent/AU2016376033A1/en not_active Abandoned
- 2016-12-19 CA CA3008996A patent/CA3008996A1/fr not_active Abandoned
- 2016-12-19 PL PL16826768.0T patent/PL3393565T3/pl unknown
-
2018
- 2018-06-01 ZA ZA2018/03662A patent/ZA201803662B/en unknown
- 2018-06-06 PH PH12018501199A patent/PH12018501199A1/en unknown
- 2018-06-10 IL IL259910A patent/IL259910A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL3393565T3 (pl) | 2023-09-11 |
| EP3393565B1 (fr) | 2023-05-24 |
| IL259910A (en) | 2018-07-31 |
| US10960152B2 (en) | 2021-03-30 |
| RU2018126867A3 (fr) | 2020-03-17 |
| UA123586C2 (uk) | 2021-04-28 |
| MX2018007512A (es) | 2018-09-17 |
| AU2016376033A1 (en) | 2018-06-28 |
| RU2720573C2 (ru) | 2020-05-12 |
| KR102697599B1 (ko) | 2024-08-23 |
| KR20180096611A (ko) | 2018-08-29 |
| JP7242300B2 (ja) | 2023-03-20 |
| PH12018501199A1 (en) | 2019-01-28 |
| RU2018126867A (ru) | 2020-01-24 |
| CN108430551A (zh) | 2018-08-21 |
| US20190001084A1 (en) | 2019-01-03 |
| ES2948157T3 (es) | 2023-09-01 |
| CA3008996A1 (fr) | 2017-06-29 |
| WO2017109678A1 (fr) | 2017-06-29 |
| ZA201803662B (en) | 2019-07-31 |
| BR112018010830A2 (pt) | 2018-11-27 |
| BR112018010830B1 (pt) | 2023-04-11 |
| JP2019508015A (ja) | 2019-03-28 |
| EP3393565A1 (fr) | 2018-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201805204WA (en) | Nicotine particle capsule | |
| SG11201805072PA (en) | Nicotine powder delivery system | |
| SG11201809040YA (en) | Hybrid aerosol-generating element and method for manufacturing a hybrid aerosol-generating element | |
| SG11201811250TA (en) | Nicotine inhaler system | |
| SG11201809594WA (en) | Nicotine particles and compositions | |
| SG11201909949XA (en) | Targeted immunotolerance | |
| SG11201804758QA (en) | Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab | |
| SG11201807401RA (en) | Therapeutic membrane vesicles | |
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201808125RA (en) | Methods for solid tumor treatment | |
| SG11201404854RA (en) | Aerosol-generating article having a flavour-generating component | |
| SG11201809630RA (en) | Nicotine particles | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201809617RA (en) | Intracellular delivery of biomolecules to induce tolerance | |
| SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| SG11201811746TA (en) | Nicotine particle delivery consumable | |
| SG11201903012RA (en) | Anti-c1s antibodies and methods of use thereof | |
| SG11201810965YA (en) | 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201808525UA (en) | Anti-complement factor bb antibodies and uses thereof | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201804598RA (en) | Flavoured nicotine powder | |
| SG11201809534UA (en) | Methods of treating autoimmune disease using allogeneic t cells | |
| SG11201810333UA (en) | Combination of anti-cd20 antibody, p13 kinase-delta selective inhibitor, and btk inhibitor to treat b-cell proliferative disorders | |
| SG11201901438VA (en) | Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate |